Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Identification of Autism Spectrum Disorder: Towards an Integrated Biomarker Approach

NCT05712512 is registered in ClinicalTrials.gov with IRCCS Eugenio Medea as lead sponsor.

NCT NCT05712512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05712512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Identification of Autism Spectrum Disorder: Towards an Integrated Biomarker Approach
Lead sponsor
IRCCS Eugenio Medea
Phase
Observational
Overall status
Completed
Start date
July 19, 2021
Completion date
March 31, 2024
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, infant development